Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.

E Faughnan, Marie; J Mager, Johannes; W Hetts, Steven; A Palda, Valerie; Lang-Robertson, Kelly; Buscarini, Elisabetta; Deslandres, Erik; S Kasthuri, Raj; Lausman, Andrea; Poetker, David; Ratjen, Felix; S Chesnutt, Mark; Clancy, Marianne; J Whitehead, Kevin; Al-Samkari, Hanny; Chakinala, Murali; Conrad, Miles; Cortes, Daniel; Crocione, Claudia; Darling, Jama; de Gussem, Els; Derksen, Carol; Dupuis-Girod, Sophie; Foy, Patrick; Geisthoff, Urban; R Gossage, James; Hammill, Adrienne; Heimdal, Ketil; Henderson, Katharine; N Iyer, Vivek; D Kjeldsen, Anette; Komiyama, Masaki; Korenblatt, Kevin; McDonald, Jamie; McMahon, Jack; McWilliams, Justin; E Meek, Mary; Mei-Zahav, Meir; Olitsky, Scott; Palmer, Sara; Pantalone, Rose; F Piccirillo, Jay; Plahn, Beth; E M Porteous, Mary; C Post, Marco; Radovanovic, Ivan; J Rochon, Paul; Rodriguez-Lopez, Josanna; Sabba, Carlo; Serra, Marcelo

doi:10.7326/m20-1443

Public

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.

Published in Annals of internal medicine • Dec 15, 2020

NobleIDark:/48914/w1/20260526/5E53B831Record on NobleID

Authors:

Marie E Faughnan

,

Johannes J Mager

,

Steven W Hetts

Abstract

DESCRIPTION: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular malformations (VMs). These result in chronic bleeding, acute hemorrhage, and complications from shunting through VMs. ...

Discussions